327 related articles for article (PubMed ID: 28722798)
1. ANGPTL8 (betatrophin) role in diabetes and metabolic diseases.
Abu-Farha M; Abubaker J; Tuomilehto J
Diabetes Metab Res Rev; 2017 Nov; 33(8):. PubMed ID: 28722798
[TBL] [Abstract][Full Text] [Related]
2. Increased plasma and adipose tissue levels of ANGPTL8/Betatrophin and ANGPTL4 in people with hypertension.
Abu-Farha M; Cherian P; Qaddoumi MG; AlKhairi I; Sriraman D; Alanbaei M; Abubaker J
Lipids Health Dis; 2018 Mar; 17(1):35. PubMed ID: 29490644
[TBL] [Abstract][Full Text] [Related]
3. Association between ANGPTL3, 4, and 8 and lipid and glucose metabolism markers in patients with diabetes.
Harada M; Yamakawa T; Kashiwagi R; Ohira A; Sugiyama M; Sugiura Y; Kondo Y; Terauchi Y
PLoS One; 2021; 16(7):e0255147. PubMed ID: 34293055
[TBL] [Abstract][Full Text] [Related]
4. Regulation of angiopoietin-like protein 8 expression under different nutritional and metabolic status.
Guo C; Zhao Z; Deng X; Chen Z; Tu Z; Yuan G
Endocr J; 2019 Dec; 66(12):1039-1046. PubMed ID: 31631098
[TBL] [Abstract][Full Text] [Related]
5. ANGPTL8/betatrophin alleviates insulin resistance via the Akt-GSK3β or Akt-FoxO1 pathway in HepG2 cells.
Rong Guo X; Li Wang X; Chen Y; Hong Yuan Y; Mei Chen Y; Ding Y; Fang J; Jiao Bian L; Sheng Li D
Exp Cell Res; 2016 Jul; 345(2):158-67. PubMed ID: 26387753
[TBL] [Abstract][Full Text] [Related]
6. Visualizing the regulatory role of Angiopoietin-like protein 8 (ANGPTL8) in glucose and lipid metabolic pathways.
Siddiqa A; Cirillo E; Tareen SHK; Ali A; Kutmon M; Eijssen LMT; Ahmad J; Evelo CT; Coort SL
Genomics; 2017 Oct; 109(5-6):408-418. PubMed ID: 28684091
[TBL] [Abstract][Full Text] [Related]
7. ANGPTL8 in metabolic homeostasis: more friend than foe?
Guo C; Wang C; Deng X; He J; Yang L; Yuan G
Open Biol; 2021 Sep; 11(9):210106. PubMed ID: 34582711
[TBL] [Abstract][Full Text] [Related]
8. Angiopoietin-like proteins 3, 4 and 8: regulating lipid metabolism and providing new hope for metabolic syndrome.
Li Y; Teng C
J Drug Target; 2014 Sep; 22(8):679-87. PubMed ID: 24960069
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the Expression and Prognostic Potential of a Novel Metabolic Regulator ANGPTL8/Betatrophin in Human Cancers.
Xu F; Tian D; Shi X; Sun K; Chen Y
Pathol Oncol Res; 2021; 27():1609914. PubMed ID: 34646087
[TBL] [Abstract][Full Text] [Related]
10. The multi-faces of Angptl8 in health and disease: Novel functions beyond lipoprotein lipase modulation.
Abu-Farha M; Ghosh A; Al-Khairi I; Madiraju SRM; Abubaker J; Prentki M
Prog Lipid Res; 2020 Nov; 80():101067. PubMed ID: 33011191
[TBL] [Abstract][Full Text] [Related]
11. ANGPTL8 roles in proliferation, metabolic diseases, hypothyroidism, polycystic ovary syndrome, and signaling pathways.
Navaeian M; Asadian S; Ahmadpour Yazdi H; Gheibi N
Mol Biol Rep; 2021 Apr; 48(4):3719-3731. PubMed ID: 33864588
[TBL] [Abstract][Full Text] [Related]
12. Genetic Mimicry Analysis Reveals the Specific Lipases Targeted by the ANGPTL3-ANGPTL8 Complex and ANGPTL4.
Landfors F; Chorell E; Kersten S
J Lipid Res; 2023 Jan; 64(1):100313. PubMed ID: 36372100
[TBL] [Abstract][Full Text] [Related]
13. New insights into ANGPTL8 in modulating the development of cardio-metabolic disorder diseases.
Su X; Zhang G; Cheng Y; Wang B
Mol Biol Rep; 2021 Apr; 48(4):3761-3771. PubMed ID: 33864591
[TBL] [Abstract][Full Text] [Related]
14. Interaction between hepatokines and metabolic diseases.
Liang JQ; Liu C; Zhang WX; Chen SY
Yi Chuan; 2022 Oct; 44(10):853-866. PubMed ID: 36384723
[TBL] [Abstract][Full Text] [Related]
15. Angptl8 antisense oligonucleotide improves adipose lipid metabolism and prevents diet-induced NAFLD and hepatic insulin resistance in rodents.
Vatner DF; Goedeke L; Camporez JG; Lyu K; Nasiri AR; Zhang D; Bhanot S; Murray SF; Still CD; Gerhard GS; Shulman GI; Samuel VT
Diabetologia; 2018 Jun; 61(6):1435-1446. PubMed ID: 29497783
[TBL] [Abstract][Full Text] [Related]
16. Effects of Angiopoietin-Like 3 on Triglyceride Regulation, Glucose Homeostasis, and Diabetes.
Christopoulou E; Elisaf M; Filippatos T
Dis Markers; 2019; 2019():6578327. PubMed ID: 30944669
[TBL] [Abstract][Full Text] [Related]
17. Deciphering the expression dynamics of ANGPTL8 associated regulatory network in insulin resistance using formal modelling approaches.
Siddiqa A; Ahmad J; Ali A; Khan S
IET Syst Biol; 2020 Apr; 14(2):47-58. PubMed ID: 32196463
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Serum ANGPTL8/betatrophin on the Risk of Developing the Metabolic Syndrome - A Prospective Study.
Wang H; Lai Y; Han C; Liu A; Fan C; Wang H; Zhang H; Ding S; Teng W; Shan Z
Sci Rep; 2016 Jun; 6():28431. PubMed ID: 27345212
[TBL] [Abstract][Full Text] [Related]
19. Altered Concentrations in Dyslipidemia Evidence a Role for ANGPTL8/Betatrophin in Lipid Metabolism in Humans.
Gómez-Ambrosi J; Pascual-Corrales E; Catalán V; Rodríguez A; Ramírez B; Romero S; Vila N; Ibáñez P; Margall MA; Silva C; Gil MJ; Salvador J; Frühbeck G
J Clin Endocrinol Metab; 2016 Oct; 101(10):3803-3811. PubMed ID: 27472196
[TBL] [Abstract][Full Text] [Related]
20. Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D.
Abu-Farha M; Al-Khairi I; Cherian P; Chandy B; Sriraman D; Alhubail A; Al-Refaei F; AlTerki A; Abubaker J
Lipids Health Dis; 2016 Oct; 15(1):181. PubMed ID: 27733177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
